🇺🇸 FDA
Pipeline program

0.9% Sodium Chloride Injection, mRNA-3705

mRNA-3705-P101

Phase 2 small_molecule active

Quick answer

0.9% Sodium Chloride Injection, mRNA-3705 for Isolated Methylmalonic Acidemia Due to Methylmalonyl-CoA Mutase Deficiency is a Phase 2 program (small_molecule) at Moderna Biotech Spain with 1 ClinicalTrials.gov record(s).

Program details

Company
Moderna Biotech Spain
Indication
Isolated Methylmalonic Acidemia Due to Methylmalonyl-CoA Mutase Deficiency
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials